DreaMed Advisor Pro— 510(k) K201476

Substantially Equivalent

DreaMed Diabetes, Ltd.

FDA 510(k) clearance K201476 for DreaMed Advisor Pro, Substantially Equivalent on 2020-08-28. Applicant: DreaMed Diabetes, Ltd..

Clearance details

Applicant: DreaMed Diabetes, Ltd.
Product code: Code QCC
Advisory panel: Clinical Chemistry
Date received: 2020-06-03
Decision date: 2020-08-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Petah Tikva, IL

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.